Evidence map›Paper›PMID 40668983›Full record

SynthesisRetina (Philadelphia, Pa.)2025

SURGICAL OUTCOMES OF LAMELLAR MACULAR HOLE EYES WITH OR WITHOUT PRESERVATION OF LAMELLAR HOLE-ASSOCIATED EPIRETINAL PROLIFERATION TECHNIQUE: A Meta-analysis.

Yi Yu, Ya-Yun Wang, Mo Tian, Xu-Hui Yu

Abstract readMeta-Analysis
In one paragraph

Synthesis in Retina (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yi YuDepartment of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China .
Ya-Yun Wang
Mo Tian
Xu-Hui Yu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate sparing or embedding technique for lamellar hole-associated epiretinal proliferation and in comparison with traditional internal limiting membrane and epiretinal membrane peeling in lamellar macular holes.

methodsPubMed, Web of Science, Medline, EMBASE, Cochrane, CNKI, Wan Fang, and VIP Databases (PROSPERO number CRD42024466392) were searched. Trials of various lamellar hole-associated epiretinal proliferation removal or preservation techniques in lamellar macular holes were included (case reports of only 1 case excluded). Postoperative changes in best-corrected visual acuity were calculated. Central retinal thickness and number of patients with new postoperative intact ellipsoid zones were secondary outcomes.

resultsEight studies were eligible and four compared with peeling groups. Preservation groups showed a significant visual improvement operatively (mean difference = -0.25 logMAR; 95% confidence interval = -0.30 to -0.21; P < 0.00001) and improved compared with peeling groups (mean difference = -0.19 logMAR; 95% confidence interval = -0.29 to -0.1; P < 0.0001). In addition, the number of patients with intact ellipsoid zones increased in the preserving groups (odd ratio = 2.55; 95% confidence interval = 1.48-4.38; P = 0.0007) and also increased compared with peeling groups (odd ratio =10.80; 95% confidence interval = 1.86-62.83; P = 0.008).

conclusionBased on the current evidence, lamellar hole-associated epiretinal proliferation sparing or embedding technique has favorable postoperative outcomes compared with peeling technique for lamellar macular holes.

Indexed as

Epiretinal MembraneRetinal PerforationsVisual AcuityVitrectomyHumansTomography, Optical CoherenceTreatment Outcomebest-corrected visual acuitycentral retinal thicknessellipsoid zoneembeddingepiretinal membranelamellar hole-associated epiretinal proliferationlamellar macular holemeta-analysissparingvitrectomy

Identifiers

PMID40668983
PMCPMC12548810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.